Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OFSA3.SA
Strong BuyOuro Fino Saúde Animal Participações S.A. · Healthcare · Brazil · $261M · Avg Vol: $39K/d
98
StockRankGet insider-trade alerts
Q
76
V
87
M
49
P/E (TTM)
5.6x
ROE
31.8%
D/E
0.6x
Dividend %
5.2%
COMPANY DESCRIPTION
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.0B | 943.3M | 1.0B | 1.2B | 5.6% | 1.4B |
| EPS (BRL) | 2.43 | -0.93 | 2.50 | 4.13 | 19.4% | 4.44 |
| Shares | 53.8M | 53.8M | 53.8M | 53.8M | 0.0% | 53.8M |
| Debt | 412.4M | 437.5M | 375.1M | 503.6M | 6.9% | 524.1M |
| Equity | 736.0M | 689.4M | 756.4M | 796.8M | 2.7% | — |
| Op CF | 89.6M | 190.3M | 73.9M | 99.9M | 3.7% | 234.8M |
| Inv CF | -78.1M | -37.1M | -42.9M | -41.8M | — | — |
| Fin CF | -8.0M | -14.4M | -102.2M | -40.6M | — | — |
Loading 1Y...
PRICE (1Y)-1.9%
SMA 50SMA 200
Close
$4.85
RSI (14)
35.3
52W High
$6.66
From 52W High
0.7%
SCORE BREAKDOWN
Quality
76
ROIC
22.2%92.5
ROE
31.8%95.0
GP/Assets
45.4%83.6
Op. Margin
16.3%77.7
FCF/Assets
8.7%82.7
Piotroski
376.5
Int. Cover
8.0x59.5
D/E Ratio
0.63x25.7
Current Ratio
3.61x60.8
Value
87
P/E (TTM)
5.6x96.8
EV/EBITDA
4.9x93.2
P/FCF
9.8x83.7
P/B
1.6x69.5
P/S
1.0x83.9
Div Yield
5.2%90.3
Momentum
49
52W High %
73%53.8
RS 6M
11%74.1
SMA 50/200
1.01x62.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-53%10.0
Q Growth
-23%21.2
FUNDAMENTALS
Market Cap
$261M
P/E (Forward)
11.8x
Gross Margin
52.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OFSA3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A.(you) | $261M | 98 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| HYPE3.SA | Hypera S.A. | $3.0B | 97 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 98 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 87 | Strong Buy |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $62M | 95 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
Peer medians: ROE 10.5% · P/E 13.3x · Gross margin 30.3%